Novavax Efficacy and Side Effects (US and Mexico Trial Results)

Novavax Efficacy and Side Effects (US and Mexico Trial Results)Show more

90% efficacy. No myocarditis, no thrombosis, no anaphylaxis, and no ADE. 100% efficacious in blacks, lowest efficacy in Hispanics and Latinos. Let's review.

If you like this content and want more, I am doing a special lifetime membership offer. Click here:
https://www.drbeen.com/yt-special/

Want to support this work?:
Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
PayPal: https://paypal.me/mobeensyed?locale.x=en_US

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

URL list from Wednesday, Mar. 23 2022

Novavax Investor Relations - Press Releases & Statements
https://ir.novavax.com/press-releases?o=20

Novavax Investor Relations - Press Releases & Statements
https://ir.novavax.com/Novavax-Statement-on-Availability-of-its-COVID-19-Vaccine-in-New-Zealand

Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial - Feb 28, 2022
https://ir.novavax.com/2022-02-28-Novavax-Announces-Extended-Durability-of-Protection-Against-Infection-and-Disease-in-United-Kingdom-COVID-19-Vaccine-Phase-3-Clinical-Trial

Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States - Feb 23, 2022
https://ir.novavax.com/2022-02-23-Novavax-Announces-Shipments-of-its-COVID-19-Vaccine-to-European-Union-Member-States

Health Canada Authorizes Novavax COVID-19 Vaccine - Feb 17, 2022
https://ir.novavax.com/2022-02-17-Health-Canada-Authorizes-Novavax-COVID-19-Vaccine

Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine - Feb 14, 2022
https://ir.novavax.com/2022-02-14-Singapore-Health-Sciences-Authority-Issues-Interim-Authorization-for-Novavax-COVID-19-Vaccine

Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland - Feb 14, 2022
https://ir.novavax.com/2022-02-14-Novavax-Files-for-Conditional-Marketing-Authorization-of-COVID-19-Vaccine-in-Switzerland

Novavax Statement on First Administration of its COVID-19 Vaccine in Australia
https://ir.novavax.com/Novavax-Statement-on-First-Administration-of-its-COVID-19-Vaccine-in-Australia

Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial - Feb 10, 2022
https://ir.novavax.com/2022-02-10-Novavax-Announces-Positive-Results-of-COVID-19-Vaccine-in-Pediatric-Population-of-PREVENT-19-Phase-3-Clinical-Trial

Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* - Feb 3, 2022
https://ir.novavax.com/2022-02-03-Medicines-and-Healthcare-Products-Regulatory-Agency-Grants-Conditional-Marketing-Authorization-for-Novavax-COVID-19-Vaccine-in-Great-Britain

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine - Jan 31, 2022
https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine

Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine - Dec 31, 2021
https://ir.novavax.com/2021-12-31-Novavax-Submits-Final-Data-Packages-to-U-S-FDA-as-Prerequisite-to-Emergency-Use-Authorization-Application-Request-for-COVID-19-Vaccine

nejmoa2116185_appendix.pdf
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_appendix.pdf

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
https://www.drbeen.com/